Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

Last Close
Feb 17  •  04:00PM ET
2.22
Dollar change
-0.14
Percentage change
-5.93
%
IndexRUT P/E- EPS (ttm)-0.37 Insider Own58.51% Shs Outstand48.46M Perf Week-25.00%
Market Cap107.78M Forward P/E1.67 EPS next Y1.33 Insider Trans-0.01% Shs Float20.14M Perf Month-33.13%
Enterprise Value1.04B PEG0.08 EPS next Q0.36 Inst Own31.46% Short Float26.42% Perf Quarter-22.92%
Income-17.97M P/S0.05 EPS this Y50.70% Inst Trans0.92% Short Ratio17.44 Perf Half Y-38.50%
Sales2.13B P/B0.41 EPS next Y24.53% ROA-1.02% Short Interest5.32M Perf YTD-38.33%
Book/sh5.43 P/C1.47 EPS next 5Y21.71% ROE-6.65% 52W High5.60 -60.36% Perf Year-37.46%
Cash/sh1.51 P/FCF1.33 EPS past 3/5Y- - ROIC-1.48% 52W Low2.12 4.72% Perf 3Y-95.53%
Dividend Est.- EV/EBITDA5.94 Sales past 3/5Y-0.94% 6.00% Gross Margin17.15% Volatility12.84% 7.54% Perf 5Y-97.41%
Dividend TTM- EV/Sales0.49 EPS Y/Y TTM94.70% Oper. Margin3.89% ATR (14)0.22 Perf 10Y-91.26%
Dividend Ex-DateApr 02, 2024 Quick Ratio1.75 Sales Y/Y TTM-5.70% Profit Margin-0.84% RSI (14)26.94 Recom2.50
Dividend Gr. 3/5Y- - Current Ratio1.75 EPS Q/Q37.66% SMA20-26.51% Beta1.09 Target Price5.00
Payout- Debt/Eq3.73 Sales Q/Q-1.89% SMA50-33.96% Rel Volume1.64 Prev Close2.36
Employees52000 LT Debt/Eq3.60 EarningsFeb 26 AMC SMA200-43.09% Avg Volume305.18K Price2.22
IPOAug 01, 1996 Option/ShortYes / Yes EPS/Sales Surpr.-46.67% 4.26% Trades Volume499,748 Change-5.93%
Date Action Analyst Rating Change Price Target Change
Nov-10-25Downgrade William Blair Outperform → Mkt Perform
Oct-01-24Upgrade Guggenheim Sell → Neutral
Mar-19-24Initiated Guggenheim Sell $8
Mar-06-24Downgrade Canaccord Genuity Buy → Hold
Mar-04-24Downgrade Barrington Research Outperform → Mkt Perform
Nov-10-23Upgrade Barrington Research Mkt Perform → Outperform $18
Aug-14-23Upgrade Morgan Stanley Underweight → Equal-Weight $31
Mar-02-23Downgrade Barrington Research Outperform → Mkt Perform
Oct-10-22Downgrade BofA Securities Buy → Neutral $68 → $48
Apr-22-22Initiated Barrington Research Outperform $100
Feb-16-26 08:00AM
Feb-11-26 04:05PM
Jan-22-26 08:59AM
Jan-15-26 05:33PM
Jan-13-26 11:40AM
07:00AM Loading…
Dec-17-25 07:00AM
Dec-11-25 05:00PM
Dec-09-25 12:20AM
Dec-08-25 12:38PM
Nov-25-25 09:14PM
Nov-20-25 08:49AM
Nov-12-25 04:30PM
Nov-10-25 09:25AM
Nov-06-25 06:45PM
05:40PM
04:05PM Loading…
04:05PM
Nov-05-25 05:15PM
Oct-15-25 05:39PM
Sep-25-25 05:33PM
Sep-08-25 09:25AM
Sep-07-25 08:15AM
Aug-25-25 04:30PM
Aug-11-25 09:00AM
07:45AM
Aug-09-25 08:08PM
03:04AM
Aug-07-25 06:00PM
04:58PM
04:05PM
Aug-04-25 06:10PM
06:07PM Loading…
Aug-01-25 06:07PM
Jul-26-25 04:57PM
Jul-21-25 04:15PM
Jul-18-25 01:09PM
Jul-15-25 08:09AM
Jul-08-25 09:00AM
08:00AM
Jul-04-25 11:40AM
Jul-01-25 08:50AM
Jun-30-25 02:41AM
Jun-18-25 11:40AM
Jun-11-25 10:53AM
Jun-02-25 11:40AM
May-30-25 12:41AM
May-28-25 08:50AM
May-15-25 11:40AM
May-13-25 08:34AM
May-12-25 08:50AM
May-10-25 03:03AM
May-08-25 05:45PM
04:45PM
04:05PM
09:46AM
May-07-25 11:21AM
09:42AM
08:20AM
May-06-25 09:36AM
May-01-25 10:01AM
Apr-29-25 11:40AM
Apr-21-25 09:05AM
Apr-15-25 08:00AM
Apr-10-25 11:40AM
Apr-04-25 08:45AM
Apr-03-25 08:08AM
Apr-01-25 04:35PM
Mar-27-25 04:00PM
Mar-26-25 01:09PM
Mar-25-25 11:40AM
Mar-17-25 04:00PM
Mar-11-25 12:20PM
Mar-05-25 08:00AM
Mar-01-25 02:34AM
02:06AM
Feb-27-25 06:20PM
05:18PM
04:05PM
07:22AM
Feb-19-25 07:59AM
Feb-17-25 01:00AM
Feb-13-25 05:33PM
Feb-10-25 10:17AM
Feb-07-25 09:00AM
Dec-19-24 08:00AM
Dec-16-24 04:00PM
Dec-12-24 08:30AM
Dec-02-24 02:00AM
Nov-30-24 04:36AM
Nov-27-24 12:01AM
Nov-20-24 07:00AM
Nov-13-24 04:30PM
Nov-08-24 08:02AM
Nov-06-24 05:40PM
04:47PM
04:05PM
07:42AM
Nov-05-24 08:02AM
Nov-01-24 07:00AM
Oct-28-24 05:40PM
10:51AM
Oct-16-24 04:05PM
TTEC Holdings, Inc. is a digital global customer experience technology and services company. It focuses on the design, implementation, and delivery of transformative solutions for many brands. The firm operates through the following segments: TTEC Digital and TTEC Engage. The TTEC Digital segment provides design, build, and operate tech-enabled, insight-driven CX solutions. The TTEC Engage segment provides digitally-enabled customer care, acquisition, and fraud prevention services. The company was founded by Kenneth D. Tuchman in 1982 and is headquartered in Austin, TX.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Anenen StevenDirectorDec 17 '25Sale3.854,00015,40053,314Dec 18 04:33 PM
Steven J. AnenenOtherDec 17 '25Proposed Sale3.854,00015,400Dec 17 04:00 PM
Seybold David J.CEO, TTEC DIGITALNov 28 '25Option Exercise0.0013,109053,636Dec 01 05:01 PM
Seybold David J.CEO, TTEC DIGITALOct 04 '25Option Exercise0.0021,477046,992Oct 06 04:30 PM
Wagers Kenneth R IIICHIEF FINANCIAL OFFICEROct 04 '25Option Exercise0.0030,068081,984Oct 06 04:30 PM
McLean Margaret BChief Legal & Risk OfficerOct 04 '25Option Exercise0.0020,618084,955Oct 06 04:30 PM
Abou John P.President, TTEC EngageOct 04 '25Option Exercise0.0020,618033,075Oct 06 04:30 PM
Abou John P.President, TTEC EngageJul 17 '25Option Exercise0.0019,480019,480Jul 21 04:33 PM
McLean Margaret BGC & CROJul 01 '25Option Exercise0.001,487064,580Jul 02 04:30 PM
McLean Margaret BGC & CROMay 30 '25Option Exercise0.009,384065,977Jun 03 04:38 PM
Wagers Kenneth R IIICHIEF FINANCIAL OFFICERMay 30 '25Option Exercise0.0012,065054,854Jun 03 04:34 PM
Seybold David J.CEO, TTEC DIGITALMay 30 '25Option Exercise0.0013,964030,612Jun 03 04:31 PM
Anenen StevenDirectorMay 22 '25Option Exercise0.0029,503057,314May 27 05:00 PM
BAHL TRACY LDirectorMay 22 '25Option Exercise0.0029,503053,420May 27 04:57 PM
Conley Gregory ADirectorMay 22 '25Option Exercise0.0029,503052,510May 27 04:53 PM
Frerichs Robert NDirectorMay 22 '25Option Exercise0.0029,503053,635May 27 04:50 PM
LOFTEN GINADirectorMay 22 '25Option Exercise0.0029,503039,680May 27 04:48 PM
Holtzman MarcDirectorMay 22 '25Option Exercise0.0029,503068,714May 27 04:44 PM
Wagers Kenneth R IIICHIEF FINANCIAL OFFICERMar 01 '25Option Exercise0.0057,678057,678Mar 04 04:30 PM
Last Close
Feb 17  •  04:00PM ET
48.65
Dollar change
-1.35
Percentage change
-2.70
%
KF Korea Fund Inc daily Stock Chart
Index- P/E20.19 EPS (ttm)2.41 Insider Own- Shs Outstand4.16M Perf Week1.71%
Market Cap202.30M Forward P/E- EPS next Y- Insider Trans- Shs Float4.16M Perf Month17.63%
Enterprise Value- PEG- EPS next Q- Inst Own74.99% Short Float0.14% Perf Quarter36.58%
Income- P/S100.06 EPS this Y- Inst Trans- Short Ratio0.33 Perf Half Y74.58%
Sales2.02M P/B1.58 EPS next Y- ROA- Short Interest0.01M Perf YTD33.95%
Book/sh30.87 P/C- EPS next 5Y- ROE- 52W High50.00 -2.70% Perf Year133.45%
Cash/sh- P/FCF- EPS past 3/5Y- - ROIC- 52W Low18.15 168.04% Perf 3Y115.42%
Dividend Est.- EV/EBITDA- Sales past 3/5Y- - Gross Margin- Volatility2.67% 2.92% Perf 5Y53.13%
Dividend TTM1.38 (2.84%) EV/Sales- EPS Y/Y TTM- Oper. Margin- ATR (14)1.37 Perf 10Y184.78%
Dividend Ex-DateDec 23, 2025 Quick Ratio- Sales Y/Y TTM- Profit Margin- RSI (14)68.86 Recom-
Dividend Gr. 3/5Y196.54% 29.46% Current Ratio- EPS Q/Q2045.90% SMA205.28% Beta1.26 Target Price-
Payout- Debt/Eq- Sales Q/Q11.90% SMA5019.02% Rel Volume0.44 Prev Close50.00
Employees- LT Debt/Eq- Earnings- SMA20053.49% Avg Volume17.81K Price48.65
IPOAug 22, 1984 Option/ShortNo / Yes EPS/Sales Surpr.- - Trades Volume7,831 Change-2.70%
Dec-12-25 08:12AM
Dec-18-24 10:40AM
Dec-16-24 04:00PM
Sep-19-24 04:30PM
Sep-17-24 09:00AM
05:25PM Loading…
Aug-16-24 05:25PM
Jul-10-24 04:31PM
Jul-01-24 04:30PM
May-16-24 02:13PM
Sep-27-23 04:00PM
Dec-16-22 10:10AM
Nov-25-22 11:18AM
Apr-14-22 03:29AM
Dec-17-21 08:23AM
Nov-30-21 11:58AM
04:20PM Loading…
Mar-02-21 04:20PM
Dec-24-20 01:05PM
Dec-18-20 04:05PM
Dec-03-20 04:05PM
Nov-30-20 04:05PM
Oct-14-20 04:05PM
Sep-30-20 04:05PM
Aug-28-20 07:11PM
04:05PM
Jun-02-20 04:05PM
May-29-20 04:05PM
Mar-23-20 04:56PM
Mar-02-20 04:39PM
Feb-28-20 04:05PM
Dec-13-19 04:05PM
04:05PM Loading…
Nov-29-19 04:05PM
Oct-17-19 04:05PM
Sep-24-19 04:15PM
Aug-29-19 04:05PM
May-30-19 04:05PM
Feb-28-19 04:05PM
Dec-14-18 04:05PM
Nov-29-18 04:05PM
Oct-17-18 04:05PM
Sep-27-18 04:05PM
Aug-29-18 04:05PM
May-30-18 04:05PM
Feb-28-18 04:05PM
Dec-15-17 04:05PM
Nov-29-17 04:00PM
Oct-31-17 04:00PM
Oct-11-17 04:00PM
Aug-29-17 04:00PM
Aug-07-17 07:19AM
May-30-17 04:15PM
04:00PM
May-24-17 08:01AM
Apr-26-17 01:48PM
Apr-18-17 08:51AM
Feb-28-17 04:00PM
Dec-21-16 11:55AM
Dec-16-16 05:04PM
Nov-29-16 04:00PM
Nov-16-16 04:30PM
Oct-24-16 12:00PM
Oct-17-16 04:00PM
Sep-26-16 04:00PM
Aug-29-16 04:00PM
May-31-16 04:00PM
Feb-29-16 04:00PM
Dec-18-15 04:00PM
Dec-01-15 07:19PM
Nov-30-15 04:00PM
Nov-02-15 04:00PM
Oct-15-15 04:00PM
Aug-28-15 04:00PM
May-29-15 04:00PM
Feb-27-15 04:00PM
Nov-28-14 01:00PM
Nov-24-14 10:55AM
Nov-03-14 04:00PM
Oct-30-14 10:50AM
Oct-27-14 12:51PM
Oct-20-14 04:00PM
Sep-12-14 07:00AM
Sep-02-14 04:00PM
Aug-29-14 04:00PM
04:00PM
Jul-30-14 04:00PM
May-30-14 04:00PM
May-06-14 02:55PM
Apr-08-14 02:35PM
Mar-26-14 04:00PM
Mar-02-14 07:00PM
Feb-28-14 04:00PM
Feb-25-14 11:00AM
Feb-20-14 04:32PM
Jan-30-14 04:00PM
Nov-29-13 04:00PM
Nov-01-13 04:00PM
Oct-16-13 12:05PM
Sep-10-13 04:00PM
Aug-30-13 04:00PM
May-29-13 04:00PM
May-13-13 11:46AM
The Korea Fund, Inc. is a closed-ended equity mutual fund launched and managed by Allianz Global Investors U.S. LLC. The fund invests in the public equity markets of Korea. It seeks to invest in stocks of companies operating across diversified sectors. The fund primarily invests in growth stocks of companies. It employs fundamental analysis with a bottom-up stock picking approach, focusing on such factors as price-to-earnings ratios, dividend yields, and earnings-per-share growth to create its portfolio. The fund benchmarks the performance of its portfolio against the MSCI Korea 25/50 Index. It uses 'Grassroots Research' to make its investments. The Korea Fund, Inc. was formed on August 29, 1984 and is domiciled in the United States.
SUPN Supernus Pharmaceuticals Inc daily Stock Chart
IndexRUT P/E- EPS (ttm)-0.34 Insider Own5.10% Shs Outstand57.12M Perf Week0.62%
Market Cap2.96B Forward P/E16.92 EPS next Y3.05 Insider Trans-11.00% Shs Float54.42M Perf Month2.71%
Enterprise Value2.72B PEG5.14 EPS next Q0.33 Inst Own104.26% Short Float7.33% Perf Quarter16.16%
Income-19.12M P/S4.34 EPS this Y-4.70% Inst Trans-2.05% Short Ratio5.94 Perf Half Y20.92%
Sales681.54M P/B2.81 EPS next Y1.84% ROA-1.38% Short Interest3.99M Perf YTD3.86%
Book/sh18.38 P/C10.53 EPS next 5Y3.29% ROE-1.86% 52W High57.65 -10.46% Perf Year31.99%
Cash/sh4.90 P/FCF41.84 EPS past 3/5Y10.33% -8.87% ROIC-1.77% 52W Low29.16 77.02% Perf 3Y31.35%
Dividend Est.- EV/EBITDA51.88 Sales past 3/5Y4.51% 11.00% Gross Margin76.08% Volatility3.30% 3.02% Perf 5Y73.51%
Dividend TTM- EV/Sales3.99 EPS Y/Y TTM-130.59% Oper. Margin-4.83% ATR (14)1.60 Perf 10Y286.67%
Dividend Ex-Date- Quick Ratio1.56 Sales Y/Y TTM4.54% Profit Margin-2.80% RSI (14)59.29 Recom1.33
Dividend Gr. 3/5Y- - Current Ratio1.80 EPS Q/Q-216.09% SMA203.77% Beta0.71 Target Price61.33
Payout0.00% Debt/Eq0.04 Sales Q/Q9.34% SMA504.20% Rel Volume1.03 Prev Close50.84
Employees674 LT Debt/Eq0.03 EarningsFeb 24 AMC SMA20020.56% Avg Volume671.93K Price51.62
IPOMay 01, 2012 Option/ShortYes / Yes EPS/Sales Surpr.70.41% 6.59% Trades Volume693,459 Change1.53%
Date Action Analyst Rating Change Price Target Change
Oct-09-25Upgrade Piper Sandler Neutral → Overweight $65
Jul-30-25Upgrade Cantor Fitzgerald Neutral → Overweight $42
Feb-19-25Downgrade Cantor Fitzgerald Overweight → Neutral $57 → $36
Jan-06-25Initiated Cantor Fitzgerald Overweight $57
Sep-11-24Downgrade Piper Sandler Overweight → Neutral $41 → $36
Jan-03-23Resumed Jefferies Buy $44 → $45
Dec-01-21Resumed Jefferies Buy $40 → $44
Apr-13-21Upgrade Jefferies Hold → Buy $25 → $40
Jun-16-20Upgrade Piper Sandler Neutral → Overweight $25 → $31
Jun-15-20Resumed Jefferies Hold $24
Today 10:00AM
Feb-16-26 11:04PM
Feb-12-26 04:35PM
Feb-06-26 11:30AM
Feb-03-26 07:56AM
06:57AM Loading…
Dec-19-25 06:57AM
Dec-03-25 04:05PM
Nov-21-25 04:06PM
11:00AM
Nov-12-25 04:05PM
Nov-11-25 12:36AM
Nov-06-25 08:07AM
Nov-05-25 12:26PM
08:37AM
12:03AM
08:30PM Loading…
Nov-04-25 08:30PM
05:20PM
04:18PM
04:12PM
04:01PM
Nov-02-25 10:01PM
Oct-30-25 02:02PM
10:00AM
Oct-29-25 05:15PM
12:00PM
09:35AM
Oct-28-25 10:00AM
09:14AM
Oct-27-25 09:15AM
Oct-24-25 10:33AM
12:10PM Loading…
Oct-22-25 12:10PM
Oct-21-25 05:00PM
Oct-16-25 03:23AM
Oct-15-25 03:08PM
Oct-13-25 12:00PM
Oct-12-25 11:31PM
Oct-10-25 11:55AM
09:15AM
Oct-09-25 12:05PM
Sep-25-25 12:00PM
Sep-23-25 09:15AM
Sep-18-25 09:17AM
Sep-16-25 12:02AM
Aug-27-25 04:15PM
Aug-13-25 12:12AM
Aug-12-25 11:43PM
Aug-11-25 08:00AM
Aug-07-25 02:00PM
Aug-06-25 01:20PM
03:27AM
Aug-05-25 08:30PM
06:35PM
06:18PM
05:32PM
04:05PM
Aug-03-25 11:08PM
Aug-01-25 07:09AM
Jul-31-25 10:48AM
08:44AM
Jul-30-25 04:05PM
12:16PM
Jul-28-25 10:24AM
08:25AM
Jul-24-25 11:33PM
Jul-22-25 04:30PM
Jul-18-25 03:10PM
Jul-14-25 12:31AM
Jun-30-25 01:43PM
Jun-27-25 05:23AM
Jun-18-25 09:45AM
Jun-17-25 02:36PM
09:16AM
Jun-16-25 04:21PM
11:43AM
09:16AM
07:42AM
07:00AM
May-29-25 08:30AM
May-28-25 04:05PM
04:05PM
May-20-25 08:30AM
May-14-25 02:29PM
May-07-25 03:20AM
12:34AM
May-06-25 10:55PM
07:00PM
05:30PM
04:08PM
Apr-30-25 07:28AM
Apr-29-25 09:05AM
Apr-28-25 12:00PM
Apr-24-25 07:46AM
Apr-23-25 05:14PM
Apr-17-25 11:08AM
Apr-04-25 05:13AM
Mar-25-25 12:53PM
Mar-17-25 09:35AM
Mar-14-25 05:01AM
Mar-13-25 09:00AM
Mar-06-25 07:24PM
Supernus Pharmaceuticals, Inc. engages in the development and commercialization of products for the treatment of central nervous system diseases. It offers Trokendi XR, Oxtellar XR, APOKYN, XADAGO, and MYOBLOC products. The company was founded by Jack A. Khattar on March 30, 2005, and is headquartered in Rockville, MD.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Hudson Frederick M.DirectorJan 09 '26Option Exercise12.9815,000194,70061,307Jan 12 04:09 PM
Mottola FrankSVP, Chief Tech. Ops. OfficerDec 19 '25Option Exercise28.8220,000576,50030,496Dec 22 04:04 PM
Mottola FrankSVP, Chief Tech. Ops. OfficerDec 19 '25Sale50.4120,0001,008,15015,496Dec 22 04:04 PM
FRANK MOTTOLAOfficerDec 19 '25Proposed Sale49.2820,000985,600Dec 19 04:23 PM
Bhatt Padmanabh P.Sr. VP of IP, CSODec 18 '25Option Exercise0.001,500015,218Dec 19 04:05 PM
Bhatt Padmanabh P.Sr. VP of IP, CSODec 18 '25Sale44.4471031,55214,508Dec 19 04:05 PM
NEWHALL CHARLES W IIIDirectorNov 21 '25Option Exercise12.9815,000194,700119,644Nov 24 06:16 PM
Khattar Jack A.President, CEOOct 09 '25Option Exercise25.3081,2502,055,6251,266,478Oct 10 05:33 PM
Khattar Jack A.President, CEOOct 09 '25Sale50.5759,9003,029,3361,206,578Oct 10 05:33 PM
NEWHALL CHARLES W IIIDirectorOct 09 '25Sale50.7725,0001,269,234104,644Oct 10 04:21 PM
JACK A. KHATTARDirectorOct 09 '25Proposed Sale48.0059,9002,875,200Oct 09 04:20 PM
CHARLES NEWHALLDirectorOct 09 '25Proposed Sale48.0025,0001,200,000Oct 09 04:19 PM
Khattar Jack A.President, CEOOct 02 '25Option Exercise0.0039,32001,192,757Oct 03 04:19 PM
Khattar Jack A.President, CEOOct 02 '25Option Exercise25.302,26757,3551,163,137Oct 03 04:18 PM
Khattar Jack A.President, CEOOct 02 '25Sale48.061,90491,5061,161,233Oct 03 04:18 PM
JACK A. KHATTARDirectorOct 02 '25Proposed Sale48.041,90491,468Oct 02 04:23 PM
Khattar Jack A.President, CEOOct 01 '25Option Exercise25.3053,7851,360,7601,201,043Oct 02 04:02 PM
Khattar Jack A.President, CEOOct 01 '25Sale48.0740,1731,931,1161,160,870Oct 02 04:02 PM
JACK A. KHATTARDirectorOct 01 '25Proposed Sale47.7940,1731,919,868Oct 01 04:28 PM
Khattar Jack A.President, CEOSep 30 '25Option Exercise25.3011,510291,2031,155,846Oct 01 04:20 PM
Khattar Jack A.President, CEOSep 30 '25Sale48.258,588414,3711,147,258Oct 01 04:20 PM
JACK A. KHATTARDirectorSep 30 '25Proposed Sale47.608,588408,789Sep 30 04:34 PM
Khattar Jack A.President, CEOSep 29 '25Option Exercise25.3013,688346,3061,154,571Sep 30 04:24 PM
Khattar Jack A.President, CEOSep 29 '25Sale48.0210,235491,4851,144,336Sep 30 04:24 PM
JACK A. KHATTARDirectorSep 29 '25Proposed Sale47.0310,235481,352Sep 29 04:37 PM
Rubin JonathanSVP, Chief Medical OfficerSep 25 '25Option Exercise0.001,875011,855Sep 26 04:17 PM
Khattar Jack A.President, CEOSep 23 '25Option Exercise12.9847,940622,2611,170,396Sep 24 04:14 PM
Khattar Jack A.President, CEOSep 23 '25Sale47.2329,5131,393,8991,140,883Sep 24 04:14 PM
Khattar Jack A.President, CEOSep 22 '25Option Exercise12.9827,060351,2391,139,043Sep 23 04:22 PM
Khattar Jack A.President, CEOSep 22 '25Sale47.0216,587779,9211,122,456Sep 23 04:22 PM
JACK A. KHATTARDirectorSep 23 '25Proposed Sale46.9829,5131,386,521Sep 23 04:21 PM
JACK A KHATTAROfficerSep 22 '25Proposed Sale46.0416,587763,665Sep 22 04:26 PM
Mottola FrankSVP, Chief Tech. Ops. OfficerSep 12 '25Option Exercise39.405,000197,00020,496Sep 15 05:39 PM
Mottola FrankSVP, Chief Tech. Ops. OfficerSep 12 '25Sale45.875,000229,35015,496Sep 15 05:39 PM
FRANK MOTTOLAOfficerSep 12 '25Proposed Sale45.875,000229,338Sep 12 04:05 PM
Khattar Jack A.President, CEOSep 08 '25Option Exercise25.308,074204,2721,118,305Sep 09 04:21 PM
Khattar Jack A.President, CEOSep 08 '25Sale46.296,322292,6451,111,983Sep 09 04:21 PM
Khattar Jack A.President, CEOSep 05 '25Option Exercise25.3073,1761,851,3531,165,809Sep 08 04:31 PM
Khattar Jack A.President, CEOSep 05 '25Sale46.0155,5782,557,1441,110,231Sep 08 04:31 PM
JACK A KHATTAROfficerSep 08 '25Proposed Sale46.006,322290,812Sep 08 04:28 PM
JACK A KHATTARDirectorSep 05 '25Proposed Sale45.4355,5782,524,909Sep 05 04:25 PM
Khattar Jack A.President, CEOAug 28 '25Option Exercise12.9838,779503,3511,116,783Aug 29 04:05 PM
Khattar Jack A.President, CEOAug 27 '25Option Exercise12.9817,195223,1911,088,654Aug 29 04:05 PM
Khattar Jack A.President, CEOAug 28 '25Sale45.1224,1501,089,6481,092,633Aug 29 04:05 PM
Khattar Jack A.President, CEOAug 27 '25Sale45.0510,650479,7821,078,004Aug 29 04:05 PM
NEWHALL CHARLES W IIIDirectorAug 27 '25Sale45.013,588161,496129,644Aug 29 04:05 PM
JACK A KHATTARDirectorAug 28 '25Proposed Sale45.0724,1501,088,440Aug 28 04:23 PM
Bhatt Padmanabh P.Sr. VP of IP, CSOAug 25 '25Option Exercise0.001,250014,299Aug 27 05:01 PM
Mottola FrankSVP, Quality, GMP, Ops, ITAug 25 '25Option Exercise12.9814,000181,72029,496Aug 27 04:59 PM
Mottola FrankSVP, Quality, GMP, Ops, ITAug 25 '25Sale44.5114,000623,14015,496Aug 27 04:59 PM
NEWHALL CHARLES W IIIDirectorAug 25 '25Sale45.001,00045,000133,232Aug 27 04:56 PM
Khattar Jack A.President, CEOAug 25 '25Option Exercise12.981,61120,9111,072,459Aug 27 04:56 PM
Khattar Jack A.President, CEOAug 25 '25Sale45.001,00045,0001,071,459Aug 27 04:56 PM
JACK A KHATTARDirectorAug 27 '25Proposed Sale44.3210,650472,008Aug 27 04:28 PM
NEWHALL CHARLES W IIIDirectorAug 22 '25Sale45.001,41263,540134,232Aug 26 04:19 PM
DEC TIMOTHY CSenior Vice-President & CFOAug 22 '25Sale44.4911,780524,0921,246Aug 26 04:18 PM
Khattar Jack A.President, CEOAug 22 '25Option Exercise12.982,41531,3471,072,348Aug 26 04:08 PM
Khattar Jack A.President, CEOAug 22 '25Sale45.001,50067,5001,070,848Aug 26 04:08 PM
JACK A KHATTARDirectorAug 25 '25Proposed Sale44.881,00044,880Aug 25 04:38 PM
CHARLES NEWHALLDirectorAug 25 '25Proposed Sale44.884,588205,909Aug 25 04:37 PM
FRANK MOTTOLAOfficerAug 25 '25Proposed Sale44.5114,000623,070Aug 25 04:09 PM
CHARLES NEWHALLDirectorAug 22 '25Proposed Sale43.321,41261,168Aug 22 05:04 PM
JACK A KHATTARDirectorAug 22 '25Proposed Sale43.321,50064,980Aug 22 04:47 PM
TIMOTHY CARROLL DECOfficerAug 22 '25Proposed Sale44.4911,780524,133Aug 22 04:26 PM
Sensenig BethanyDirectorAug 14 '25Sale42.255,369226,8400Aug 18 04:31 PM
Hudson Frederick M.DirectorAug 14 '25Sale42.267,457315,13346,307Aug 18 04:28 PM
FREDERICK M HUDSONDirectorAug 14 '25Proposed Sale42.267,457315,116Aug 14 04:33 PM
BETHANY SENSENIGDirectorAug 14 '25Proposed Sale42.645,369228,934Aug 14 04:22 PM
Khattar Jack A.President, CEOAug 06 '25Option Exercise17.95201,2503,613,2251,133,433Aug 08 04:40 PM
Khattar Jack A.President, CEOAug 06 '25Sale42.02140,0005,883,3601,030,183Aug 08 04:40 PM
JACK A KHATTARDirectorAug 06 '25Proposed Sale37.53140,0005,254,200Aug 06 04:23 PM
Khattar Jack A.President, CEOMar 10 '25Option Exercise0.0035,00001,008,638Mar 11 04:17 PM
DEC TIMOTHY CSenior Vice-President & CFOMar 10 '25Option Exercise0.003,800013,636Mar 11 04:15 PM
Khattar Jack A.President, CEOMar 07 '25Option Exercise0.0038,6400992,219Mar 07 04:40 PM
Mottola FrankSVP, Quality, GMP, Ops, ITMar 07 '25Option Exercise0.002,625016,507Mar 07 04:34 PM
Mottola FrankSVP, Quality, GMP, Ops, ITFeb 26 '25Option Exercise0.005,760017,683Feb 26 05:56 PM
Bhatt Padmanabh P.Sr. VP of IP, CSOFeb 21 '25Option Exercise0.001,650011,799Feb 24 08:22 PM
Rubin JonathanSVP, Chief Medical OfficerFeb 21 '25Option Exercise0.001,87508,780Feb 24 08:20 PM
Rubin JonathanSVP, Chief Medical OfficerFeb 21 '25Sale39.1592736,2927,853Feb 24 08:20 PM
Mottola FrankSVP, Quality, GMP, Ops, ITFeb 21 '25Option Exercise0.001,12509,576Feb 24 08:18 PM
Last Close
Feb 17  •  04:00PM ET
103.31
Dollar change
+0.07
Percentage change
0.07
%
EXAS Exact Sciences Corp daily Stock Chart
Index- P/E- EPS (ttm)-1.10 Insider Own1.93% Shs Outstand190.80M Perf Week-0.01%
Market Cap19.71B Forward P/E88.49 EPS next Y1.17 Insider Trans-0.70% Shs Float187.13M Perf Month0.95%
Enterprise Value21.28B PEG- EPS next Q-0.20 Inst Own88.11% Short Float3.55% Perf Quarter52.49%
Income-207.95M P/S6.07 EPS this Y122.15% Inst Trans-12.07% Short Ratio1.27 Perf Half Y126.56%
Sales3.25B P/B8.21 EPS next Y379.20% ROA-3.39% Short Interest6.65M Perf YTD1.72%
Book/sh12.58 P/C20.43 EPS next 5Y- ROE-8.66% 52W High103.54 -0.22% Perf Year109.51%
Cash/sh5.06 P/FCF55.25 EPS past 3/5Y32.20% 27.36% ROIC-4.25% 52W Low38.81 166.18% Perf 3Y62.74%
Dividend Est.- EV/EBITDA322.95 Sales past 3/5Y15.92% 16.84% Gross Margin69.69% Volatility0.25% 0.33% Perf 5Y-26.73%
Dividend TTM- EV/Sales6.55 EPS Y/Y TTM-353.69% Oper. Margin-4.79% ATR (14)0.40 Perf 10Y1462.93%
Dividend Ex-Date- Quick Ratio2.17 Sales Y/Y TTM17.69% Profit Margin-6.40% RSI (14)74.19 Recom2.88
Dividend Gr. 3/5Y- - Current Ratio2.43 EPS Q/Q90.29% SMA200.58% Beta1.41 Target Price104.00
Payout- Debt/Eq1.06 Sales Q/Q23.12% SMA501.19% Rel Volume0.33 Prev Close103.24
Employees7200 LT Debt/Eq1.04 EarningsFeb 13 AMC SMA20050.37% Avg Volume5.23M Price103.31
IPOJan 31, 2001 Option/ShortYes / Yes EPS/Sales Surpr.-317.05% 2.03% Trades Volume1,742,830 Change0.07%
Date Action Analyst Rating Change Price Target Change
Jan-20-26Downgrade Mizuho Outperform → Neutral $105
Jan-05-26Downgrade Evercore ISI Outperform → In-line $105
Apr-10-25Initiated Mizuho Outperform $60
Mar-13-25Initiated RBC Capital Mkts Sector Perform $52
Jan-23-25Initiated Barclays Overweight $70
Aug-28-24Initiated Wells Fargo Overweight $75
Jun-27-24Initiated Scotiabank Sector Outperform $70
Jun-03-24Resumed Jefferies Buy $75
Jan-02-24Upgrade The Benchmark Company Hold → Buy $91
Dec-14-23Initiated Guggenheim Buy $90
Feb-16-26 10:57PM
11:40AM
Feb-13-26 05:15PM
04:21PM
04:05PM
01:04PM Loading…
Feb-12-26 01:04PM
Feb-09-26 11:01AM
Feb-08-26 11:04PM
Feb-06-26 05:41PM
Feb-03-26 02:32PM
09:03AM
08:30AM
Feb-02-26 12:05PM
Jan-28-26 06:46AM
Jan-27-26 11:40AM
07:46AM Loading…
07:46AM
Jan-26-26 06:40AM
Jan-22-26 04:02PM
04:01PM
02:16PM
09:48AM
08:53AM
Jan-20-26 08:47AM
07:55AM
Jan-13-26 01:00PM
Jan-12-26 07:51AM
Jan-09-26 02:24PM
Jan-08-26 04:30PM
12:48PM
12:21PM
12:31PM Loading…
Jan-07-26 12:31PM
11:52AM
11:49AM
Jan-06-26 11:18AM
11:00AM
Jan-04-26 11:32PM
Dec-31-25 07:25AM
Dec-30-25 07:32AM
07:32AM
Dec-26-25 01:48PM
Dec-16-25 02:09PM
Dec-15-25 02:59PM
Dec-11-25 05:30PM
Dec-10-25 11:35PM
Dec-08-25 01:35AM
Dec-05-25 09:41AM
Dec-03-25 11:30AM
Dec-02-25 04:54AM
Dec-01-25 12:33PM
Nov-30-25 02:05AM
Nov-28-25 12:41PM
Nov-25-25 09:36AM
09:17AM
01:33AM
Nov-24-25 04:35PM
09:41AM
09:20AM
Nov-23-25 10:30PM
Nov-21-25 09:10AM
07:32AM
06:30AM
04:50AM
03:35AM
Nov-20-25 07:50PM
07:43PM
06:29PM
05:06PM
05:05PM
04:44PM
04:23PM
04:15PM
04:14PM
03:31PM
03:08PM
03:03PM
03:01PM
02:47PM
01:36PM
01:02PM
12:01PM
11:51AM
11:32AM
10:21AM
09:41AM
09:31AM
09:26AM
08:43AM
08:09AM
07:46AM
07:46AM
07:30AM
06:27AM
Nov-19-25 07:21PM
04:57PM
04:31PM
04:27PM
02:36PM
11:19AM
06:22AM
Nov-17-25 01:13PM
EXACT Sciences Corp. is a cancer screening and diagnostics company. The firm focuses on the early detection and prevention of some forms of cancer. It offers a non-invasive screening test called Cologuard for the early detection of colorectal cancer and pre-cancer and Oncotype DX. The company was founded on February 10, 1995, and is headquartered in Madison, WI.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
ORVILLE JACOB AEVP, GM, ScreeningDec 23 '25Option Exercise0.0073,080069,511Dec 30 04:30 PM
Baranick BrianEVP, GM, Precision OncologyDec 23 '25Option Exercise0.0073,080066,487Dec 30 04:30 PM
Condella SarahEVP, Human ResourcesDec 23 '25Option Exercise0.0047,2080118,059Dec 30 04:30 PM
Herriott JamesSVP, General Counsel & SecDec 23 '25Option Exercise0.0033,780032,934Dec 30 04:30 PM
Bloomer AaronEVP, Chief Financial OfficerDec 23 '25Option Exercise0.0063,099059,571Dec 30 04:30 PM
ORVILLE JACOB AEVP, GM, ScreeningNov 19 '25Sale75.005,000375,00023,237Nov 21 05:30 PM
Herriott JamesSVP, General Counsel & SecNov 19 '25Sale70.001,00070,00011,585Nov 21 05:30 PM
ORVILLE JACOB AOfficerNov 19 '25Proposed Sale75.005,000375,000Nov 19 03:11 PM
Herriott JamesOfficerNov 19 '25Proposed Sale70.001,00070,000Nov 19 12:04 PM
Herriott JamesSVP, General Counsel & SecNov 04 '25Sale70.081,500105,12012,585Nov 06 05:29 PM
Baranick BrianEVP, GM, Precision OncologyNov 04 '25Sale70.082,858200,28922,368Nov 06 05:29 PM
Baranick BrianOfficerNov 04 '25Proposed Sale70.082,858200,289Nov 04 10:25 AM
Herriott JamesOfficerNov 04 '25Proposed Sale70.081,500105,120Nov 04 10:22 AM
Zanotti Katherine SDirectorOct 24 '25Sale65.0012,000780,00060,759Oct 27 08:35 PM
Zanotti Katherine SDirectorOct 24 '25Proposed Sale65.0012,000780,000Oct 24 11:08 AM
Herriott JamesSVP, General Counsel & SecOct 09 '25Sale60.001,50090,00014,085Oct 10 05:27 PM
Doyle James EdwardDirectorOct 09 '25Sale60.002,000120,00057,962Oct 10 05:25 PM
Herriott JamesOfficerOct 09 '25Proposed Sale60.001,50090,000Oct 09 11:23 AM
Doyle James EdwardDirectorOct 09 '25Proposed Sale60.002,000120,000Oct 09 11:18 AM
Doyle James EdwardDirectorAug 13 '25Sale42.021,48562,40059,962Aug 14 04:30 PM
Doyle James EdwardDirectorAug 13 '25Proposed Sale42.021,48562,400Aug 13 10:09 AM
ORVILLE JACOB AEVP, GM, ScreeningAug 05 '25Option Exercise0.005,350030,752Aug 07 05:30 PM
Baranick BrianEVP, GM, Precision OncologyAug 05 '25Option Exercise0.005,350027,943Aug 07 05:30 PM
Sebelius KathleenFormer DirectorJul 16 '25Proposed Sale53.118,164433,605Jul 16 04:22 PM
Zanotti Katherine SDirectorJun 13 '25Sale53.203,207170,61272,759Jun 16 05:30 PM
Zanotti Katherine SDirectorJun 13 '25Proposed Sale53.203,207170,612Jun 13 09:50 AM
Bloomer AaronEVP, Chief Financial OfficerApr 15 '25Option Exercise0.0024,460019,340Apr 17 04:30 PM
Conroy Kevin TPresident and CEOMar 07 '25Option Exercise22.3866,7231,493,2611,203,269Mar 10 05:00 PM
Herriott JamesSVP, General Counsel & SecFeb 28 '25Option Exercise0.004,265016,339Mar 04 04:48 PM
Conroy Kevin TPresident and CEOFeb 28 '25Option Exercise0.0040,31001,146,965Mar 04 04:47 PM
Baranick BrianEVP, GM, Precision OncologyFeb 28 '25Option Exercise0.009,673025,106Mar 04 04:44 PM
ORVILLE JACOB AEVP, GM, ScreeningFeb 28 '25Option Exercise0.009,673027,728Mar 04 04:40 PM
Condella SarahEVP, Human ResourcesFeb 28 '25Option Exercise0.007,738084,399Mar 04 04:37 PM
Condella SarahEVP, Human ResourcesFeb 25 '25Option Exercise0.003,954080,297Feb 26 08:00 PM
Baranick BrianEVP, GM, Precision OncologyFeb 25 '25Option Exercise0.003,954019,841Feb 26 08:00 PM
Herriott JamesSVP, General Counsel & SecFeb 25 '25Option Exercise0.001,647013,738Feb 26 08:00 PM
ORVILLE JACOB AEVP, GM, ScreeningFeb 25 '25Option Exercise0.003,954022,136Feb 26 08:00 PM
Conroy Kevin TPresident and CEOFeb 25 '25Option Exercise0.0013,18001,121,378Feb 26 08:00 PM
Conroy Kevin TPresident and CEOFeb 19 '25Option Exercise0.0010,37401,084,565Feb 21 04:30 PM
COWARD D SCOTTDirectorFeb 19 '25Option Exercise0.002,248052,831Feb 21 04:30 PM
ORVILLE JACOB AEVP, GM, ScreeningFeb 19 '25Option Exercise0.002,248016,688Feb 21 04:30 PM
Baranick BrianEVP, GM, Precision OncologyFeb 19 '25Option Exercise0.001,729014,487Feb 21 04:30 PM
Condella SarahEVP, Human ResourcesFeb 19 '25Option Exercise0.002,248074,859Feb 21 04:30 PM
Herriott JamesSVP, General Counsel & SecFeb 19 '25Option Exercise0.00865010,731Feb 21 04:30 PM
Last Close
Feb 17  •  04:00PM ET
67.88
Dollar change
+0.51
Percentage change
0.76
%
EZU iShares MSCI EMU ETF daily Stock Chart
CategoryGlobal or ExUS Equities - Broad / Regional Asset TypeEquities (Stocks) TagsEurope Return% 1Y32.92% Total Holdings232 Perf Week-0.75%
SponsorBlackrock (iShares) ETF Type TagsEurozone Return% 3Y18.45% AUM9.88B Perf Month2.97%
Fund Family Bond Type Tagsequity Return% 5Y11.24% NAV/sh Perf Quarter7.17%
IndexMSCI EMU Index Average Maturity Tagsmid-large-cap Return% 10Y 52W High68.55 -0.98% Perf Half Y11.21%
Index Weighting Commodity Type Tags- Return% SI 52W Low47.11 44.09% Perf YTD5.90%
Active/Passive Quant Type Tags- Flows% 1M2.21% Volatility1.06% 1.03% Perf Year27.76%
Dividend TTM1.83 (2.69%) ESG Type Tags- Flows% 3M7.13% ATR (14)0.78 Perf 3Y51.75%
Dividend Ex-DateDec 16, 2025 Dividend Type Sector/Theme Flows% YTD4.47% RSI (14)59.16 Perf 5Y49.36%
Dividend Gr. 3/5Y18.34% 14.28% Structure Type Region Flows% 1Y Beta0.92 Perf 10Y109.63%
Expense0.50% Growth/Value SMA201.20% Flows% 3Y Rel Volume1.07 Prev Close67.37
Inverse/Leveraged Market Cap SMA503.54% Flows% 5Y Avg Volume1.67M Price67.88
IPOJul 31, 2000 Option/ShortYes / Yes SMA20010.25% Trades Volume1,782,203 Change0.76%
Jan-22-26 09:50AM
Jan-05-26 08:00AM
Dec-29-25 08:00AM
Dec-24-25 11:00AM
Nov-21-25 10:16AM
11:16AM Loading…
Nov-13-25 11:16AM
Oct-30-25 07:31PM
Jul-31-25 06:32AM
Jul-03-25 06:00AM
Jun-06-25 01:00PM
11:30AM
Jun-03-25 10:45AM
May-30-25 06:20AM
May-07-25 11:50AM
11:30AM
07:05AM Loading…
07:05AM
May-05-25 08:41AM
08:00AM
07:04AM
May-03-25 03:40AM
12:30AM
May-02-25 11:15PM
07:45AM
06:00AM
May-01-25 02:10PM
04:00AM
Apr-30-25 06:00PM
09:36AM
04:35AM
04:10AM
03:35AM Loading…
03:35AM
Apr-29-25 06:35AM
04:35AM
03:15AM
02:35AM
Apr-28-25 05:30AM
Apr-26-25 04:22AM
Apr-25-25 07:40AM
04:20AM
03:45AM
Apr-24-25 07:22AM
05:50AM
Apr-23-25 07:25AM
07:07AM
05:45AM
04:30AM
03:10AM
Apr-22-25 11:03AM
Apr-19-25 02:25AM
Apr-17-25 12:06PM
05:35AM
04:30AM
03:20AM
Apr-16-25 04:05AM
02:40AM
Apr-15-25 10:15PM
03:46PM
11:58AM
11:35AM
08:40AM
08:40AM
07:45AM
04:52AM
04:30AM
04:10AM
Apr-14-25 06:20AM
02:30AM
Apr-12-25 05:00AM
12:30AM
Apr-11-25 05:05AM
04:30AM
Apr-10-25 10:05AM
08:00AM
04:30AM
Apr-09-25 08:23AM
04:50AM
Apr-08-25 06:20AM
04:25AM
Apr-07-25 12:30PM
11:48AM
Apr-04-25 02:30PM
04:55AM
04:00AM
03:40AM
Apr-03-25 10:45PM
09:40AM
05:05AM
02:32AM
02:15AM
Apr-02-25 05:30AM
05:30AM
03:30AM
12:50AM
Apr-01-25 07:29AM
04:20AM
12:16AM
Mar-29-25 05:45AM
02:50AM
02:45AM
12:50AM
iShares MSCI Eurozone ETF seeks to track the investment results of the MSCI EMU Index composed of large- and mid-capitalization equities from developed market countries that use the euro as their official currency. The fund generally will invest at least 80% of its assets in the component securities of its underlying index and in investments that have economic characteristics that are substantially identical to the component securities of its underlying index. The index consists of securities from the following 10 developed market countries: Austria, Belgium, Finland, France, Germany, Ireland, Italy, the Netherlands, Portugal and Spain.
Last Close
Feb 17  •  04:00PM ET
50.54
Dollar change
+0.45
Percentage change
0.90
%
EFNL iShares MSCI Finland ETF daily Stock Chart
CategoryGlobal or ExUS Equities - Country Specific Asset TypeEquities (Stocks) TagsFinland Return% 1Y48.93% Total Holdings41 Perf Week-0.36%
SponsorBlackrock (iShares) ETF Type Tagsequity Return% 3Y13.49% AUM37.49M Perf Month2.95%
Fund Family Bond Type Tags- Return% 5Y6.02% NAV/sh Perf Quarter9.72%
IndexMSCI Finland IMI 25/50 Index Average Maturity Tags- Return% 10Y 52W High52.03 -2.85% Perf Half Y20.69%
Index Weighting Commodity Type Tags- Return% SI 52W Low32.62 54.94% Perf YTD5.69%
Active/Passive Quant Type Tags- Flows% 1M0.00% Volatility1.10% 1.06% Perf Year41.49%
Dividend TTM1.62 (3.22%) ESG Type Tags- Flows% 3M7.49% ATR (14)0.69 Perf 3Y31.50%
Dividend Ex-DateDec 16, 2025 Dividend Type Sector/Theme Flows% YTD14.81% RSI (14)57.05 Perf 5Y9.38%
Dividend Gr. 3/5Y-9.90% 4.56% Structure Type Region Flows% 1Y Beta0.74 Perf 10Y65.92%
Expense0.53% Growth/Value SMA201.05% Flows% 3Y Rel Volume0.62 Prev Close50.09
Inverse/Leveraged Market Cap SMA504.11% Flows% 5Y Avg Volume8.44K Price50.54
IPOJan 26, 2012 Option/ShortNo / Yes SMA20015.52% Trades Volume5,265 Change0.90%
Feb-04-22 05:38PM
Dec-09-19 02:31AM
Apr-09-19 08:00AM
Feb-27-19 01:00PM
Jun-14-17 03:34PM
04:33PM Loading…
May-02-17 04:33PM
Apr-24-17 10:07AM
Dec-23-15 10:16AM
Nov-11-15 11:40AM
Oct-01-15 07:30AM
Sep-14-15 06:01AM
Jul-13-15 11:16AM
Apr-04-15 12:01AM
Mar-09-15 07:30AM
Mar-05-15 04:29PM
09:00AM Loading…
Jan-08-15 09:00AM
Dec-11-14 03:42PM
Nov-05-14 08:20AM
Aug-26-14 02:12PM
Aug-20-14 11:17AM
Jul-10-14 01:46PM
Jul-08-14 09:00AM
Apr-30-14 02:46PM
Jan-27-14 09:00AM
Jan-03-14 01:43PM
Dec-01-13 07:45AM
Nov-15-13 08:15AM
Nov-13-13 09:20AM
Oct-04-13 12:27PM
Sep-03-13 03:16PM
08:25AM Loading…
Jun-12-13 08:25AM
Mar-28-13 04:00AM
Sep-07-12 12:40PM
Sep-06-12 10:33AM
Jun-22-12 04:00AM
Jun-12-12 07:57AM
Jun-11-12 10:24AM
Jun-04-12 10:28AM
May-29-12 07:58AM
May-15-12 05:50PM
May-14-12 04:31PM
May-11-12 04:01PM
May-10-12 11:38AM
Apr-08-12 02:10AM
Feb-28-12 10:21AM
Feb-09-12 03:50PM
Feb-07-12 06:01PM
Feb-06-12 05:05PM
11:02AM
Feb-03-12 10:57AM
Jan-31-12 07:00AM
Jan-30-12 06:01PM
05:16PM
Jan-28-12 10:00AM
Jan-27-12 07:01AM
06:00AM
Jan-12-12 07:54PM
iShares MSCI Finland ETF seeks to track the investment results of the MSCI Finland IMI 25/50 Index. The fund generally will invest at least 80% of its assets in the component securities of the underlying index and in investments that have economic characteristics that are substantially identical to the component securities of the underlying index. The index is designed to measure the performance of the large-, mid- and small-capitalization segments of the equity market in Finland. The underlying index uses a capping methodology that limits the weight of any single "group entity" to a maximum of 25% of the underlying index weight. The fund is non-diversified.